Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome

NCT06895473 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Hematopoietic and Lymphatic System Neoplasm

Interventions

PROCEDURE: Biospecimen Collection
DRUG: Cytarabine
PROCEDURE: Lumbar Puncture
DRUG: Methotrexate
DRUG: Therapeutic Hydrocortisone

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]
[object Object]